Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2005-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJPS.2005.03.001PMID 15911222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 6′7′‐Dihydroxybergamottin Contributes to the Grapefruit Juice Effect

  2004cited by this paper
• Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.

  2004cited by this paper
• Contributions of CYP3A4, P-glycoprotein, and Serum Protein Binding to the Intestinal First-Pass Extraction of Saquinavir

  2004cited by this paper
• Absorption and metabolism of flavonoids.

  2004cited by this paper
• Flavonoids and isoflavones: absorption, metabolism, and bioactivity.

  2004cited by this paper
• Organic cation transporters.

  2003cited by this paper
• Inhibition of Cytochrome P450 3A: Relevant Drug Interactions in Gastroenterology

  2003cited by this paper
• Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice

  2003cited by this paper
• Interaction between flavonoids and the blood–brain barrier: in vitro studies

  2003cited by this paper
• Rapid Assessment of P-Glycoprotein Inhibition and Induction in Vitro

  2003cited by this paper
• Effect of the Flavonoids Biochanin A and Silymarin on the P-Glycoprotein-Mediated Transport of Digoxin and Vinblastine in Human Intestinal Caco-2 Cells

  2003cited by this paper
• Allosteric Modulation of Human P-glycoprotein

  2003cited by this paper
• Influence of Drugs and Nutrients on Transporter Gene Expression Levels in Caco-2 and LS180 Intestinal Epithelial Cell Lines

  2003cited by this paper
• Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus

  2002cited by this paper
• Intake of grapefruit juice alters the metabolic pattern of cyclosporin A in renal transplant recipients.

  2002cited by this paper
• Seville orange juice‐felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins

  2001cited by this paper
• Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol.

  2001cited by this paper
• Rational use of in vitro P-glycoprotein assays in drug discovery.

  2001cited by this paper
• Effect of Grapefruit Juice on Pharmacokinetics of Microemulsion Cyclosporine in African American Subjects Compared with Caucasian Subjects: Does Ethnic Difference Matter?

  2001cited by this paper
• Characterization of MPP+ secretion across human intestinal Caco‐2 cell monolayers: role of P‐glycoprotein and a novel Na+‐dependent organic cation transport mechanism

  2000cited by this paper
• Grapefruit‐felodipine interaction: Effect of unprocessed fruit and probable active ingredients

  2000cited by this paper
• Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

  2000cited by this paper
• Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters

  2000cited by this paper
• The organic cation transporter OCT2 mediates the uptake of β‐adrenoceptor antagonists across the apical membrane of renal LLC‐PK1 cell monolayers

  2000cited by this paper
• Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.

  1999cited by this paper
• The molecular interaction of the high affinity reversal agent XR9576 with P‐glycoprotein

  1999cited by this paper
• Prooxidant toxicity of polyphenolic antioxidants to HL‐60 cells: description of quantitative structure‐activity relationships

  1999cited by this paper
• Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β‐glucosidase activity

  1998cited by this paper
• beta-Glucosidase activity in the rat small intestine toward quercetin monoglucosides.

  1998cited by this paper
• Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells

  1998cited by this paper
• The interaction effect of grapefruit juice is maximal after the first glass

  1998cited by this paper
• P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.

  1998cited by this paper
• Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.

  1998cited by this paper
• Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).

  1998cited by this paper
• P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels.

  1998cited by this paper
• Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

  1997cited by this paper
• Analysis of the Major Flavonol Glycosides Present in Four Varieties of Onion (Allium cepa) and Changes in Composition Resulting from Autolysis

  1997cited by this paper
• Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.

  1997cited by this paper
• Evidence for Intestinal Secretion as an Additional Clearance Pathway of Talinolol Enantiomers: Concentration- and Dose-dependent Absorption in Vitro and in Vivo

  1996cited by this paper
• Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.

  1996cited by this paper
• Flavonoids as antioxidant agents: importance of their interaction with biomembranes.

  1995cited by this paper
• Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.

  1994cited by this paper
• CONTENT OF POTENTIALLY ANTICARCINOGENIC FLAVONOIDS OF TEA INFUSIONS, WINES, AND FRUIT JUICES

  1993cited by this paper
• Commonly occurring plant flavonoids have estrogenic activity.

  1993cited by this paper
• Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands.

  1993cited by this paper
• Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators.

  1993cited by this paper
• Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells.

  1993cited by this paper
• Mammalian beta-glucuronidase: genetics, molecular biology, and cell biology.

  1989cited by this paper
• Transport of tetraethylammonium by a kidney epithelial cell line (LLC-PK1).

  1988cited by this paper
• The flavonoids. A class of semi-essential food components: their role in human nutrition.

  1976cited by this paper
• The flavonoids. A class of semi-essential food components: their role in human nutrition.

  1976cited by this paper

• The effects of low-dose X-ray pre-irradiation followed by 4-hydroxybenzoic acid and vanillic acid on P-glycoprotein-mediated efflux pirarubicin in multidrug-resistant K562/Dox cells.

  2026cites this paper
• Evaluation of the Pharmacokinetic Interactions of Maytenus ilicifolia Mart. ex Reiss Extracts on Drug Intestinal Permeability and Hepatic Metabolism

  2025cites this paper
• Phytochemical composition, phytotoxicity, and ADME modeling of Artemisia absinthium L.: implications for food safety and pharmaceutical applications

  2025cites this paper
• Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity.

  2023cites this paper
• The Role of P-Glycoprotein (P-gp) in Cancer Multidrug Resistance (MDR): Challenges for Inhibiting P-gp in the Context of Overcoming MDR

  2023cites this paper
• Discovery of the toxicity-related quality markers and mechanisms of zhi-zi-hou-Po decoction based on chinmedomics combined with differential absorbed components and network pharmacology.

  2023cites this paper
• 3D-QSAR analysis of the interactions of flavonoids with human organic cation transporter 2.

  2022cites this paper
• Contribution of Biotransformations Carried Out by the Microbiota, Drug-Metabolizing Enzymes, and Transport Proteins to the Biological Activities of Phytochemicals Found in the Diet.

  2021cites this paper
• Human variability in influx and efflux transporters in relation to uncertainty factors for chemical risk assessment.

  2020cites this paper
• Formulation and in vitro Evaluation of Hesperidin-Phospholipid Complex and its Antioxidant Potential

  2020cites this paper
• Acute regulation of apical ABC transporters in the gut. Potential influence on drug bioavailability.

  2020cites this paper
• Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance

  2020cites this paper
• Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents.

  2020cites this paper
• Chemotherapeutic Efficacy Enhancement in P-gp-Overexpressing Cancer Cells by Flavonoid-Loaded Polymeric Micelles

  2020cites this paper
• Quantitative Structure⁻Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells.

  2019cites this paper
• Flavonoids as P-gp inhibitors: a systematic review of SARs.

  2019cites this paper
• Considerations for the Use of Polyphenols as Therapies in Neurodegenerative Diseases

  2019cites this paper
• Mechanism of Synergy Between Tetracycline and Quercetin Against Antibiotic Resistant Escherichia coli

  2019cites this paper
• Determination of Subcellular Localization of Flavonol in Cultured Cells by Laser Scanning

  2018cites this paper
• Coadministration of antiepileptic drugs and P-glycoprotein inhibitors of flavonoid-type

  2018cites this paper
• Using Dictyostelium discoideum to develop flavonoid therapeutics for polycystic kidney disease : the role of MATE transporters

  2018cites this paper
• Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans?

  2018cites this paper
• Experimental modelling of flavonoid membrane interactions

  2017cites this paper
• Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative

  2017cites this paper
• Intestinal transport of HDND-7, a novel hesperetin derivative, in in vitro MDCK cell and in situ single-pass intestinal perfusion models

  2017cites this paper
• Food and Drug Interactions

  2017cites this paper
• Cancer chemoprevention through dietary flavonoids: what’s limiting?

  2017cites this paper
• Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition

  2017cites this paper
• A GENERAL REVIEW ON DRUG-FOOD INTERACTIONS, COUNSELES OF PHARMACIST DR. KLODIOLA DHAMO*

  2016cites this paper
• Absorption and disposition of naringenin and quercetin after simultaneous administration via intestinal perfusion in mice.

  2016cites this paper
• Pharmacokinetic herb–drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research

  2016influential citation
• Quercetin induces hepatic γ-glutamyl hydrolase expression in rats by suppressing hepatic microRNA rno-miR-125b-3p.

  2015cites this paper
• Revisión Interactions between antiarrhythmic drugs and food

  2015cites this paper
• Natural products-friends or foes?

  2015cites this paper
• Disposition of flavonoids impacts their efficacy and safety.

  2015cites this paper
• Flavonoid compounds as reversal agents of the P-glycoprotein-mediated multidrug resistance: biology, chemistry and pharmacology

  2015cites this paper
• High-dose short-term administration of naringin did not alter talinolol pharmacokinetics in humans.

  2015cites this paper
• A comparison of the pharmacokinetics of three different preparations of total flavones of Hippophae rhamnoides in beagle dogs after oral administration

  2015cites this paper
• Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin

  2014cites this paper
• Isoquercitrin: pharmacology, toxicology, and metabolism.

  2014cites this paper
• Effect of single-dose and short-term administration of quercetin on the pharmacokinetics of talinolol in humans - Implications for the evaluation of transporter-mediated flavonoid-drug interactions.

  2014cites this paper
• Quercetin declines plasma exposure of metoprolol tartrate in the rat model

  2014cites this paper
• Yeast as a biosensor of detoxification: a tool for identifying new compounds that revert multidrug resistance.

  2013cites this paper
• Inhibitory effects of apigenin and kaempferol on the essential solute carrier transporters

  2013cites this paper
• Anti-cancer potential of flavonoids: recent trends and future perspectives

  2013cites this paper
• Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice

  2012cites this paper
• Interactions between antihypertensive drugs and food.

  2012cites this paper
• Dynamic Analysis of GI Absorption and Hepatic Distribution Processes of Telmisartan in Rats Using Positron Emission Tomography

  2012cites this paper
• Flavone potently stimulates an apical transporter for flavonoids in human intestinal Caco-2 cells.

  2012cites this paper
• Interactions between antiarrhythmic drugs and food.

  2012cites this paper
• Revisión Interactions between antihypertensive drugs and food

  2012cites this paper
• Flavonoids and Drug Interactions

  2012cites this paper
• Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents

  2012cites this paper
• RP-HPLC stability-indicating assay method for talinolol and characterization of its degradation products.

  2011cites this paper
• In vivo probes of drug transport: commonly used probe drugs to assess function of intestinal P-glycoprotein (ABCB1) in humans.

  2011cites this paper
• Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens.

  2011cites this paper
• The effect of grapefruit juice on drug disposition

  2011cites this paper
• In situ study of the effect of naringin, talinolol and protein-energy undernutrition on intestinal absorption of saquinavir in rats.

  2011cites this paper
• A stereospecific HPLC method and its application in determination of pharmacokinetics profile of two enantiomers of naringenin in rats.

  2011cites this paper
• [Clinical relevance of drug interactions].

  2011cites this paper
• Determination of Subcellular Localization of Flavonol in Cultured Cells by Laser Scanning

  2011cites this paper
• Design and characterization of enzymatic deglycosylation systems to produce drugs against Alzheimer’s disease

  2010cites this paper
• Effects of Curcuma spp. on P-glycoprotein function.

  2010cites this paper
• Herbal Supplement-Based Interactions

  2010cites this paper
• Quercetin, quercetrin except rutin potentially increased pirarubicin cytotoxicity by non-competitively inhibiting the P-glycoprotein-and MRP1 function in living K562/adr and GLC4/adr cells

  2010influential citation
• Solubility, Stability, Physicochemical Characteristics and In Vitro Ocular Tissue Permeability of Hesperidin: A Natural Bioflavonoid

  2009cites this paper
• DietaryregulationofP-gp functionandexpression

  2009cites this paper
• Grapefruit-drug interaction: isolation, synthesis, and biological activities of furocoumarins and their variation due to pre- and post-harvest factors.

  2009cites this paper
• Quercetin and naringenin transport across human intestinal Caco-2 cells.

  2009cites this paper
• Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs.

  2009cites this paper
• Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles.

  2009cites this paper
• Subcellular localization of flavonol aglycone in hepatocytes visualized by confocal laser scanning fluorescence microscope

  2009cites this paper
• Phenolic Contribution of South African Herbal Teas to a Healthy Diet

  2009cites this paper
• Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement.

  2009cites this paper
• Quercetin and naringenin transport across human intestinal Caco‐2 cells

  2009cites this paper
• Inhibition of P-Glycoprotein Enhances the Suppressive Effect of Kaempferol on Transformation of the Aryl Hydrocarbon Receptor

  2009cites this paper
• Allopurinol, rutin and quercetin attenuate hyperuricemia and

  2009cites this paper
• Dietary regulation of P-gp function and expression

  2009cites this paper
• Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats

  2009cites this paper
• Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats.

  2008cites this paper
• Effects of Citrus Fruit Juices on Organic Cation Transporter 2 Function and Expression in Vitro

  2008influential citation
• Effect of dietary flavonoids on pathways involved in drug metabolism

  2008cites this paper
• Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.

  2008cites this paper
• Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models

  2008cites this paper
• The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a−/−) mice, a model of inflammatory bowel diseases

  2008cites this paper
• Interacciones medicamentosas: aproximación para establecer y evaluar su relevancia clínica

  2007cites this paper
• P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model.

  2007cites this paper
• Overlapping ligand specificity of P-glycoprotein and serum alpha(1)-acid glycoprotein: evidences and potential implications.

  2007cites this paper
• Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco‐2 cells

  2007cites this paper
• Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells.

  2007cites this paper
• Caco-2 cell cultures in the assessment of intestinal absorption: Effects of some co-administered drugs and natural compounds in biological matrices

  2006cites this paper
• Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans

  2006cites this paper
• Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies.

  2006cites this paper
• Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.

  2006cites this paper
• The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms.

  2006cites this paper
• The uptake behaviors of kaempferol and quercetin through rat primary cultured cortical neurons.

  2006cites this paper
• EFFECT OF GRAPEFRUIT JUICE ON P-GLYCOPROTEIN ACTIVITY

  2006cites this paper
• Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells.

  2005cites this paper